The abstract is read at the publisher; the summary is JClub's.
Endothelial KLK8 is strongly upregulated in streptozotocin-induced diabetic mice and high-glucose–treated glomerular endothelial cells, and its loss improves albuminuria and glomerular pathology.
- Why it matters: Diabetic nephropathy involves unclear endothelial-cell pathways, and identifying KLK8-linked mechanisms could reveal actionable targets for disease progression.
- What they did: The study used global and endothelial-specific Klk8 knockout mice plus endothelial Klk8 knockdown in DBA/2J mice, alongside single-cell RNA sequencing, proteomics, and pathway testing; KLK8 cleavage of SDC4 and PLC/ERK/RUNX1-driven LIFR regulation were examined.
- The result: Lifr knockdown ameliorated DN hallmarks, improved endothelial-to-mesenchymal transition and SDC4 expression, and patient data showed KLK8 is positively correlated with LIF, soluble SDC4, and creatinine.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.